The Resource An original institutionalist approach to the structure, conduct, and performance of the pharmaceutical industry : the importance of intangible assets, Avraham Izhar Baranes

An original institutionalist approach to the structure, conduct, and performance of the pharmaceutical industry : the importance of intangible assets, Avraham Izhar Baranes

Label
An original institutionalist approach to the structure, conduct, and performance of the pharmaceutical industry : the importance of intangible assets
Title
An original institutionalist approach to the structure, conduct, and performance of the pharmaceutical industry
Title remainder
the importance of intangible assets
Statement of responsibility
Avraham Izhar Baranes
Creator
Contributor
Author
Degree supervisor
Subject
Genre
Language
eng
Summary
This dissertation presents an examination of the pharmaceutical industry with a primary focus on the importance of intangible assets from the original institutional economics perspective. This is done in three main chapters. The first main chapter examines the importance of intangible assets within the context of the heterodox theory of the business enterprise. It is argued that in the early stage of the going concern {u2013} where production is separate from consumption {u2013} intangible assets necessitate the creation of monetary bargaining transactions. In industrial capitalism {u2013} with the internal separation of the enterprise into industrial and pecuniary divisions {u2013} intangible assets take the form of rationing transactions, limiting the number of sellers of a particular product. As the enterprise then evolves into its modern joint-stock form in money manager capitalism, intangible assets become the basis for capitalization, upon which incorporeal property may be issued, increasing the return to shareholders. The second main chapter discusses the structure and performance of the pharmaceutical industry. Based on the concept of centralized private sector planning and Alfred Chandler{u2019}s theory of learned organizational capabilities, I develop a core nexus understanding of pharmaceutical industry activity. The core is seen as made up of 15 firms who dictate the direction and evolution of the industry as a whole. I then examine the performance of this core using measurements of financial ratios. Measuring performance in this way is consistent with the stated motives of the business enterprise under money manager capitalism, which embodies the dominance of pecuniary habits of thought over industrial ones. The third main chapter combines the first two, examining one specific member of the core {u2013} the Pfizer Corporation {u2013} and examines the importance of intangible assets on its activity. Over time, it is shown that Pfizer has become more reliant on intangible assets as an overall portion of total assets, its net tangible assets {u2013} the book value of the company {u2013} has become negative, and Pfizer relies more heavily on drugs obtained through acquisition, rather than internal development. Money manager capitalism, as a regime of accumulation, rewards enterprises that take on an intangible characteristic. In the pharmaceutical industry, this is done with the aid of mergers and acquisitions due to accounting rules for intangible items such as goodwill and the division of labor between the core and nexus. Dominant pharmaceutical firms, then, should be seen as rent-collecting institutions, as opposed to productive entities
Cataloging source
UMK
http://library.link/vocab/creatorDate
1989-
http://library.link/vocab/creatorName
Baranes, Avraham Izhar
Degree
Ph.D.
Dissertation note
(Department of Economics and Social Sciences Consortium).
Dissertation year
2016.
Granting institution
University of Missouri-Kansas City,
Illustrations
illustrations
Index
no index present
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
  • theses
http://library.link/vocab/relatedWorkOrContributorName
Sturgeon, James I.
http://library.link/vocab/subjectName
  • Pfizer Inc
  • Pharmaceutical industry
  • Intangible property
Label
An original institutionalist approach to the structure, conduct, and performance of the pharmaceutical industry : the importance of intangible assets, Avraham Izhar Baranes
Instantiates
Publication
Note
  • "A dissertation in Economics and Social Sciences Consortium ."
  • Advisor: James I. Sturgeon
  • Vita
Antecedent source
not applicable
Bibliography note
Includes bibliographical references (pages 207-235)
Carrier category
online resource
Carrier category code
cr
Carrier MARC source
rdacarrier
Color
black and white
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Contents
Introduction -- Intangible assets and the business enterprise: understanding corporate control over social relations -- Structure and performance of the pharmaceutical industry: an original institutional economic perspective -- Intangible assets and the Pfizer Corporation: the importance of mergers, acquisition, and strategic dealings -- Conclusion
Control code
951438760
Dimensions
unknown
Extent
1 online resource (236 pages)
File format
one file format
Form of item
online
Level of compression
mixed
Media category
computer
Media MARC source
rdamedia
Media type code
c
Other physical details
illustrations.
Quality assurance targets
not applicable
Specific material designation
remote
System control number
(OCoLC)951438760
System details
  • The full text of the dissertation is available as an Adobe Acrobat .pdf file; Adobe Acrobat Reader required to view the file
  • Mode of access: World Wide Web
Label
An original institutionalist approach to the structure, conduct, and performance of the pharmaceutical industry : the importance of intangible assets, Avraham Izhar Baranes
Publication
Note
  • "A dissertation in Economics and Social Sciences Consortium ."
  • Advisor: James I. Sturgeon
  • Vita
Antecedent source
not applicable
Bibliography note
Includes bibliographical references (pages 207-235)
Carrier category
online resource
Carrier category code
cr
Carrier MARC source
rdacarrier
Color
black and white
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Contents
Introduction -- Intangible assets and the business enterprise: understanding corporate control over social relations -- Structure and performance of the pharmaceutical industry: an original institutional economic perspective -- Intangible assets and the Pfizer Corporation: the importance of mergers, acquisition, and strategic dealings -- Conclusion
Control code
951438760
Dimensions
unknown
Extent
1 online resource (236 pages)
File format
one file format
Form of item
online
Level of compression
mixed
Media category
computer
Media MARC source
rdamedia
Media type code
c
Other physical details
illustrations.
Quality assurance targets
not applicable
Specific material designation
remote
System control number
(OCoLC)951438760
System details
  • The full text of the dissertation is available as an Adobe Acrobat .pdf file; Adobe Acrobat Reader required to view the file
  • Mode of access: World Wide Web

Library Locations

  • St. Louis Mercantile LibraryBorrow it
    1 University Blvd, St. Louis, MO, 63121, US
    38.710138 -90.311107
  • Thomas Jefferson LibraryBorrow it
    1 University Blvd, St. Louis, MO, 63121, US
    38.710138 -90.311107
  • University ArchivesBorrow it
    703 Lewis Hall, Columbia, MO, 65211, US
  • University of Missouri-St. Louis Libraries DepositoryBorrow it
    2908 Lemone Blvd, Columbia, MO, 65201, US
    38.919360 -92.291620
  • University of Missouri-St. Louis Libraries DepositoryBorrow it
    2908 Lemone Blvd, Columbia, MO, 65201, US
    38.919360 -92.291620
  • Ward E Barnes Education LibraryBorrow it
    8001 Natural Bridge Rd, St. Louis, MO, 63121, US
    38.707079 -90.311355
Processing Feedback ...